J. Greengard

发表

Protein C Deficiency: A Database of Mutations, 1995 Update

P. Reitsma, F. Bernardi, I. Witt, 1995, Thrombosis and Haemostasis.

Isolation and functional characterization of the active light chain of activated human blood coagulation factor XI.

J. Griffin, D. Kerbiriou, B. Bouma, 1983, The Journal of biological chemistry.

Variability of Thrombosis among Homozygous Siblings with Resistance to Activated Protein C Due to an Arg-to-Gln Mutation in the Gene for Factor V

J. Griffin, S. Eichinger, K. Bauer, 1994 .

Use of a generally applicable tissue factor--dependent factor V assay to detect activated protein C-resistant factor Va in patients receiving warfarin and in patients with a lupus anticoagulant.

J. Griffin, S. Rapaport, D. Le, 1995, Blood.

Activated Protein C Resistance: Molecular Mechanisms

J. Griffin, J. A. Fernandez, T. Hackeng, 1995, Thrombosis and Haemostasis.

Genetic Induction of a Releasable Pool of Factor VIII in Human Endothelial Cells

R. Montgomery, J. Rosenberg, J. Greengard, 2000, Arteriosclerosis, thrombosis, and vascular biology.

Incidence of activated protein C resistance caused by the ARG 506 GLN mutation in factor V in 113 unrelated symptomatic protein C-deficient patients. The French Network on the behalf of INSERM.

J. Griffin, B. Jude, J. Abgrall, 1995, Blood.

Activated protein C resistance caused by Arg506Gln mutation in factor Va

B. Evatt, X. Xu, J. Greengard, 1994, The Lancet.

C-deficient newborn with massive thrombosis large family of a previously described homozygous protein R506Q mutation of factor V and for T298M mutation of protein C in a Venous thromboembolism associated with double heterozygosity for

J. Griffin, B. Brenner, U. Seligsohn, 2011 .

Venous thromboembolism associated with double heterozygosity for R506Q mutation of factor V and for T298M mutation of protein C in a large family of a previously described homozygous protein C-deficient newborn with massive thrombosis

J. Griffin, B. Brenner, U. Seligsohn, 1996 .

J. Griffin, B. Brenner, U. Seligsohn, 1996, Blood.

Alternative PCR method for diagnosis of mutation causing activated protein C resistant Gln506-factor V.

J. Griffin, S. Gandrille, J. Greengard, 1995, Thrombosis research.

Binding of coagulation factor XI to washed human platelets.

J. Griffin, P. Walsh, M. J. Heeb, 1986, Biochemistry.

A comparison of the abilities of plasma kallikrein, beta-Factor XIIa, Factor XIa and urokinase to activate plasminogen.

J. Griffin, L. Miles, J. Greengard, 1983, Thrombosis research.

Models of the serine protease domain of the human antithrombotic plasma factor activated protein C and its zymogen

J. Griffin, C. Fisher, J. Greengard, 1994, Protein science : a publication of the Protein Society.

Protein C inhibitor is expressed in tubular cells of human kidney.

J. Griffin, J. A. Fernandez, D. Loskutoff, 1994, The Journal of clinical investigation.

Animal Testing of Retroviral-Mediated Gene Therapy for Factor VIII Deficiency

D. Jolly, J. Greengard, J. Greengard, 1999, Thrombosis and Haemostasis.

Activated protein C resistance: molecular mechanisms based on studies using purified Gln506-factor V.

J. Griffin, M. J. Heeb, Y. Kojima, 1995, Blood.

High molecular weight kininogen receptor.

J. Griffin, J. Greengard, 1992, Methods in enzymology.

Two Mutations in the Promoter Region of the Human Protein C Gene Both Cause Type I Protein C Deficiency by Disruption of Two HNF-3 Binding Sites (*)

P. Reitsma, J. Griffin, R. Bertina, 1995, The Journal of Biological Chemistry.

Receptors for high molecular weight kininogen on stimulated washed human platelets.

J. Griffin, J. Greengard, 1984, Biochemistry.

Elucidating the structural chemistry of glycosaminoglycan recognition by protein C inhibitor.

J. Tainer, L. Kuhn, J. Griffin, 1990, Proceedings of the National Academy of Sciences of the United States of America.

Possible Structural Implications of 20 Mutations in the Protein C Protease Domain

J. Griffin, C. Fisher, J. Greengard, 1994, Thrombosis and Haemostasis.

Identification of candidate residues for interaction of protein S with C4b binding protein and activated protein C.

J. Griffin, K. Radtke, José A. Fernández, 1995, The Biochemical journal.

Structural basis for type I and type II deficiencies of antithrombotic plasma protein C: Patterns revealed by three‐dimensional molecular modelling of mutations of the protease domain

J. Griffin, B. Villoutreix, C. Fisher, 1994, Proteins.

Protein S, an Antithrombotic Factor, Is Synthesized and Released by Neural Tumor Cells

José A Fernández, J. Griffin, B. Evatt, 1993, Journal of neurochemistry.

Characterization of a cDNA for Rhesus Monkey Protein C Inhibitor – Evidence for N-Terminal Involvement in Heparin Stimulation

José A Fernández, J. Griffin, B. Villoutreix, 1995, Thrombosis and Haemostasis.

Activated protein C resistance: molecular mechanisms based on studies using purified Gln506-factor V.

J. Griffin, Y. Kojima, J. Greengard, 1995, Blood.